Til behandling af lungehindekræft blev Alimta anvendt i én hovedundersøgelse hos 456 patienter, der ikke tidligere havde fået kemoterapi mod sygdommen.
For the treatment of malignant pleural mesothelioma, Alimta has been studied in one main study in 456 patients who had not received chemotherapy for their disease before.